Xiaoxia Dai

Dr. Xiaoxia Dai

College of Chemistry and Chemical Engineering, Hunan University, Changsha 410082, China
orcid

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 November 2023 in Nature
Verified
Journal Article
Open access
PDF file
YSYuxiang Sun
Yuxiang Sun
HDHui Dai
Hui Dai
XDXiaoxia Dai
Xiaoxia Dai
JYJiekai Yin
Jiekai Yin
YCYuxiang Cui
Yuxiang Cui
YWYinsheng Wang
Yinsheng Wang
Microsatellite repeat expansions within genes contribute to a number of neurological diseases1,2. The accumulation of toxic proteins and RNA molecules with repetitive sequences, and/or sequestration of RNA-binding proteins by RNA molecules containing expanded repeats are thought to be important contributors to disease aetiology3–9. Here we reveal that the adenosine in CAG repeat RNA can be methylated to N1-methyladenosine (m1A) by TRMT61A, and that m1A can be demethylated by ALKBH3. We also observed that the m1A/adenosine ratio in CAG repeat RNA increases with repeat length, which is attributed to diminished expression of ALKBH3 elicited by the repeat RNA. Additionally, TDP-43 binds directly and strongly with m1A in RNA, which stimulates the cytoplasmic mis-localization and formation of gel-like aggregates of TDP-43, resembling the observations made for the protein in neurological diseases. Moreover, m1A in CAG repeat RNA contributes to CAG repeat expansion-induced neurodegeneration in Caenorhabditis elegans and Drosophila. In sum, our study offers a new paradigm of the mechanism through which nucleotide repeat expansion contributes to neurological diseases and reveals a novel pathological function of m1A in RNA. These findings may provide an important mechanistic basis for therapeutic intervention in neurodegenerative diseases emanating from CAG repeat expansion.

1 July 2012 in Molecular & Cellular Proteomics
Verified
Journal Article
Open access
PDF file
FZFan Zhang
Fan Zhang
XDXiaoxia Dai
Xiaoxia Dai
YWYinsheng Wang
Yinsheng Wang
5-Aza-2′-deoxycytidine (5-Aza-CdR), a nucleoside analog that can inhibit DNA cytosine methylation, possesses potent antitumorigenic activities for myeloid disorders. Although 5-Aza-CdR is known to be incorporated into DNA and inhibit DNA (cytosine-5)-methyltransferases, the precise mechanisms underlying the drug9s antineoplastic activity remain unclear. Here we utilized a mass spectrometry-based quantitative proteomic method to analyze the 5-Aza-CdR-induced perturbation of protein expression in Jurkat-T cells at the global proteome scale. Among the ∼2780 quantified proteins, 188 exhibited significant alteration in expression levels upon a 24-hr treatment with 5 μm 5-Aza-CdR. In particular, we found that drug treatment led to substantially reduced expression of farnesyl diphosphate synthase (FDPS) and farnesyl diphosphate farnesyltransferase (FDFT1), two important enzymes involved in de novo cholesterol synthesis. Consistent with this finding, 5-Aza-CdR treatment of leukemia (Jurkat-T, K562 and HL60) and melanoma (WM-266–4) cells led to a marked decrease in cellular cholesterol content and pronounced growth inhibition, which could be rescued by externally added cholesterol. Exposure of these cells to 5-Aza-CdR also led to epigenetic reactivation of dipeptidyl peptidase 4 (DPP4) gene. Additionally, suppression of DPP4 expression with siRNA induced elevated protein levels of FDPS and FDFT1, and increased cholesterol biosynthesis in WM-266–4 cells. Together, the results from the present study revealed, for the first time, that 5-Aza-CdR exerts its cytotoxic effects in leukemia and melanoma cells through epigenetic reactivation of DPP4 gene and the resultant inhibition of cholesterol biosynthesis in these cells.

1 August 2010 in Biomedical and Environmental Sciences
Verified
Journal Article
Closed access
RARun An
Run An
JMJie Meng
Jie Meng
QSQi Shi
Qi Shi
XDXiaoxia Dai
Xiaoxia Dai
JCJinghong Chen
Jinghong Chen
XDXiaoping Dong
Xiaoping Dong

31 December 2024 in Journal of the American Chemical Society
Verified
Journal Article
Open access
SWSongbo Wei
Songbo Wei
XDXiaoxia Dai
Xiaoxia Dai
JYJun Yuan
Jun Yuan
SHShiyang He
Shiyang He
KSKriti Shah
Kriti Shah
YWYinsheng Wang
Yinsheng Wang
Pseudouridine (Ψ) is the most abundant RNA modification in nature; however, not much is known about the biological functions of this modified nucleoside. Employing an unbiased quantitative proteomics method, we identified multiple candidate reader proteins of Ψ in RNA, including a cytoskeletal protein profilin-1 (PFN1). We demonstrated that PFN1 binds directly and selectively to Ψ-containing RNA. Additionally, we discovered approximately 4000 binding sites of PFN1 in human cells, including a known dyskerin (DKC1)-installed Ψ site in TPI1 mRNA, which encodes triosephosphate isomerase. Moreover, we showed that PFN1 and DKC1 are crucial for regulating the stability and translation efficiency of TPI1 mRNA through modulating PFN1-Ψ interaction. Together, we identified PFN1 as a reader protein of Ψ in RNA and illustrated a potential role of PFN1-Ψ interaction in post-transcriptional regulation. These findings provide new insights into the functions of Ψ in RNA biology and in modulating the expression of an important metabolic enzyme.

1 May 2022 in Chinese Chemical Letters
Verified
Journal Article
Closed access
YSYuwei Sheng
Yuwei Sheng
MZMeijuan Zhou
Meijuan Zhou
CYChangjun You
Changjun You
XDXiaoxia Dai
Xiaoxia Dai

28 February 2023 in Journal of Proteome Research
Verified
Journal Article
Closed access
XZXiaofang Zheng
Xiaofang Zheng
SCSijia Chang
Sijia Chang
YLYini Liu
Yini Liu
XDXiaoxia Dai
Xiaoxia Dai
CYChangjun You
Changjun You